Updated estimates of pharmaceutical company payments to physicians in Vermont.

Pharmaceutical company payments to physicians: early experiences with disclosure laws in Vermont and Minnesota.

CONTEXT Recent legislation in 5 states and the District of Columbia mandated state disclosure of payments made to physicians by pharmaceutical companies. In 2 of these states, Vermont and Minnesota, payment disclosures are publicly available. OBJECTIVES To determine the accessibility and quality of the data available in Vermont and Minnesota and to describe the prevalence and magnitude of dis...

Are Pharmaceutical Company Payments Incentivising Malpractice in Japanese Physicians?

US drug marketing: how does promotion correspond with health value?

The pharmaceutical industry uses a variety of techniques to promote its products to clinicians, including gifts and free food, advertisements, and detailing by company representatives. Although manufacturers might argue that drug promotion supports physician education, which in turn leads to more informed prescribing, studies have shown that greater contact with drug sales representatives is as...

Serial inebriate programs: what to do about homeless alcoholics in the emergency department.

clinical research: issues for clinical investigators. Acad Med. 2003;78:769-774. 37. Mirowski P, Van Horn R. The contract research organization and the commercialization of scientific research. Social Studies of Science. 2005;35:503-548. 38. American Medical Student Association. Principles regarding pharmaceuticals and medical devices. Available at: http://www. amsa.org/about/ppp/pharm.cfm. Acc...

Characteristics of physicians receiving large payments from pharmaceutical companies and the accuracy of their disclosures in publications: an observational study

BACKGROUND Financial relationships between physicians and industry are extensive and public reporting of industry payments to physicians is now occurring. Our objectives were to describe physician recipients of large total payments from these seven companies, and to examine discrepancies between these payments and conflict of interest (COI) disclosures in authors' concurrent publications. MET...